Disposition of the Company's earnings

The annual general meeting resolved that no dividend shall be paid to the shareholders for the financial year 2021 and that the funds at disposal of the meeting of SEK 206,372,093.25 shall be balanced in new accounts.

Discharge from liability

The board members and the CEO were granted discharge from liability for the financial year 2021.

Election of board of directors, auditors, and remuneration

The annual general meeting resolved, in accordance with the proposal of the nomination committee, that the number of board members shall be five (5) members without deputies.

The annual general meeting resolved, in accordance with the proposal of the nomination committee, to re-elect Staffan Torstensson, Erland Pontusson, Fredrik Celsing and Johanne Louise Brændgaard and elect of Anna Ljung as board members. Rikard Akhtarzand has declined re-election. It was resolved, in accordance with the proposal of the nomination committee, to re-elect Staffan Torstensson as chairman of the board of directors.

It was resolved, in accordance with the proposal of the nomination committee, to re-elect Öhrlings PricewaterhouseCoopers AB as accounting firm. Öhrlings PricewaterhouseCoopers AB has announced that Magnus Thorling will be appointed as auditor in charge.

It was resolved, in accordance with the proposal of the nomination committee, that board renumeration shall be paid with SEK 250,000 to the chairman of the board of directors and SEK 125,000 to each non-employed board member, corresponding to a total of SEK 750,000. It was resolved, in accordance with the proposal of the nomination committee, that renumeration to members of the audit committee shall be paid with SEK 50,000 to the chairman and SEK 25,000 to each member.

Furthermore, it was resolved that renumeration to the auditor shall be paid in accordance with approved invoice and that no renumeration shall be paid to the members of the nomination committee.

Resolution to amend the articles of association

The annual general meeting resolved to amend the articles of association by way of removal of deputy auditors in section 8 of the articles of association, meaning that section 8 of the articles of association now reads as follows:

§ 8 Auditors
An ordinary auditor shall be appointed for a review of the company's annual accounts and the management of the board of directors and the CEO.

Authorization of the board of directors to issue shares/warrants/convertible debentures

It was resolved to authorize the board of directors, within the limits of the current articles of association, on one or more occasions, with or without deviation from the shareholders' preferential rights, to resolve on the issue of shares, warrants and/or convertible debentures.

The issue of new shares pursuant to the authorization shall be carried out on customary terms under current market conditions.

For further information:
Rikard Akhtarzand, VD
+46765-25 90 71
rikard.akhtarzand@addvisegroup.se

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment and services to healthcare and research facilities. The Group's subsidiaries are organized into two business areas: Lab and healthcare. Sales are global. The Group has a clear acquisition strategy of increasing shareholder value through growth - both geographically and by product range. ADDvise shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, 08-503 015 50, CA@mangold.se,is the company's Certified Adviser. Further information is available at www.addvisegroup.com.